Phase I/II Study of Bortezomib-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Relapsed Indolent Non-Hodgkin Lymphoma, Transformed, or Mantle Cell Lymphoma-Reference-Cited by-同舟云学术

Phase I/II Study of Bortezomib-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Relapsed Indolent Non-Hodgkin Lymphoma, Transformed, or Mantle Cell Lymphoma

Published:2014-04 Issue:4 Volume:20 Page:536-542
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

William Basem M.,Allen Mary S.,Loberiza Fausto R.,Bociek Robert Gregory,Bierman Philip J.,Armitage James O.,Vose Julie M.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference32 articles.

1. High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial;Schouten;J Clin Oncol,2003

2. Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study;Sebban;J Clin Oncol,2008

3. Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up;Rohatiner;J Clin Oncol,2007

4. High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol;Brice;Ann Oncol,2000

5. Transformed lymphoma: an Achilles' heel of non-Hodgkin's lymphoma;Lerner;Bone Marrow Transplant,2003

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma;Cancers;2023-03-31

2. Hodgkin's Lymphoma;Reference Module in Biomedical Sciences;2023

3. The safety of available chemo-free treatments for mantle cell lymphoma;Expert Opinion on Drug Safety;2020-10-05

4. Mantle cell lymphoma;Critical Reviews in Oncology/Hematology;2020-09

5. Emerging therapies in mantle cell lymphoma;Journal of Hematology & Oncology;2020-06-17